Literature DB >> 24358002

Serotonin syndrome.

Jacqueline Volpi-Abadie1, Adam M Kaye2, Alan David Kaye2.   

Abstract

BACKGROUND: Serotonin syndrome is a potentially life-threatening syndrome that is precipitated by the use of serotonergic drugs and overactivation of both the peripheral and central postsynaptic 5HT-1A and, most notably, 5HT-2A receptors. This syndrome consists of a combination of mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity. Serotonin syndrome can occur via the therapeutic use of serotonergic drugs alone, an intentional overdose of serotonergic drugs, or classically, as a result of a complex drug interaction between two serotonergic drugs that work by different mechanisms. A multitude of drug combinations can result in serotonin syndrome.
METHODS: This review describes the presentation and management of serotonin syndrome and discusses the drugs and interactions that can precipitate this syndrome with the goal of making physicians more alert and aware of this potentially fatal yet preventable syndrome.
CONCLUSION: Many commonly used medications have proven to be the culprits of serotonin syndrome. Proper education and awareness about serotonin syndrome will improve the accuracy of diagnosis and promote the institution of the appropriate treatment that may prevent significant morbidity and mortality.

Entities:  

Keywords:  Drug toxicity; serotonin syndrome

Year:  2013        PMID: 24358002      PMCID: PMC3865832     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  23 in total

1.  Serotonin syndrome during treatment with paroxetine and risperidone.

Authors:  S Hamilton; K Malone
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

2.  Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome.

Authors:  K Nisijima; T Yoshino; K Yui; S Katoh
Journal:  Brain Res       Date:  2001-01-26       Impact factor: 3.252

3.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

4.  Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression.

Authors:  Whorra P Chander; Navdeep Singh; Gulshan K Mukhiya
Journal:  J Indian Med Assoc       Date:  2011-01

5.  Possible serotonin syndrome associated with tramadol and sertraline coadministration.

Authors:  B J Mason; K H Blackburn
Journal:  Ann Pharmacother       Date:  1997-02       Impact factor: 3.154

Review 6.  Prevention, recognition, and management of serotonin syndrome.

Authors:  Adrienne Z Ables; Raju Nagubilli
Journal:  Am Fam Physician       Date:  2010-05-01       Impact factor: 3.292

7.  Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome.

Authors:  Koichi Nisijima; Katsutoshi Shioda; Tatuki Yoshino; Kenji Takano; Satoshi Kato
Journal:  Neurochem Int       Date:  2003-07       Impact factor: 3.921

8.  Risperidone counteracts lethality in an animal model of the serotonin syndrome.

Authors:  K Nisijima; T Yoshino; T Ishiguro
Journal:  Psychopharmacology (Berl)       Date:  2000-05       Impact factor: 4.530

9.  Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice.

Authors:  Meredith A Fox; Catherine L Jensen; Pamela S Gallagher; Dennis L Murphy
Journal:  Neuropharmacology       Date:  2007-07-27       Impact factor: 5.250

Review 10.  Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.

Authors:  S C Stanford; B J Stanford; P K Gillman
Journal:  J Psychopharmacol       Date:  2009-05-07       Impact factor: 4.153

View more
  59 in total

1.  A Case of Serotonin Syndrome Following Cyproheptadine Withdrawal.

Authors:  Manjeet S Bhatia; Jaswinder Kaur; Priyanka Gautam
Journal:  Prim Care Companion CNS Disord       Date:  2015-05-21

Review 2.  Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.

Authors:  Rupal Dosi; Annirudh Ambaliya; Harshal Joshi; Rushad Patell
Journal:  BMJ Case Rep       Date:  2014-06-23

Review 3.  Neurotoxicology Syndromes Associated with Drugs of Abuse.

Authors:  Rachel A Caplan; Jonah P Zuflacht; Jed A Barash; Corey R Fehnel
Journal:  Neurol Clin       Date:  2020-11       Impact factor: 3.806

4.  Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Authors:  Benjamin J Malcolm; Kelly C Lee
Journal:  Ment Health Clin       Date:  2018-03-23

5.  Recent publications by ochsner authors: october 2013 - march 2014.

Authors: 
Journal:  Ochsner J       Date:  2014

Review 6.  Safety profile of lamotrigine in overdose.

Authors:  Akintunde Alabi; Adam Todd; Andrew Husband; Joe Reilly
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

7.  A Veteran Presenting With Altered Mental Status and Clonus.

Authors:  Zachary Reese; Jason Weller; Deepa Rangachari; Benjamin Schlechter; Anthony C Breu
Journal:  Fed Pract       Date:  2020-04

8.  PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT1A Receptor and Upregulation of Nrf2-Dependent GSH Synthesis.

Authors:  Hai-Quyen Tran; Youngho Lee; Eun-Joo Shin; Choon-Gon Jang; Ji Hoon Jeong; Akihiro Mouri; Kuniaki Saito; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2018-02-22       Impact factor: 5.590

9.  Serotonin Syndrome With Fluoxetine: Two Case Reports.

Authors:  Dipen Dineshkumar Patel; David Galarneau
Journal:  Ochsner J       Date:  2016

Review 10.  Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Authors:  Hossein Ansari; Leila Kouti
Journal:  Curr Pain Headache Rep       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.